Treatment of locoregional recurrent colon cancer

Handtrack C, Weber K, Merkel S, Grützmann R, Denz A (2022)

Publication Type: Journal article

Publication year: 2022

Journal

Abstract

The local recurrence rate of colon cancer could be markedly reduced after complete mesocolic excision (CME) criteria were implemented in oncological surgery. Risk factors for local recurrence include incomplete resection as well as the site of the primary tumor and locally or lymph node advanced tumors (pT4/pN2). Further risk factors are emergency operations and postoperative complications, particularly anastomotic leakage. The outcome of local recurrent colon cancer is decisively influenced by the resectability. In cases of a curative R0 resection, possibly including neoadjuvant therapy or multivisceral resections, a 5-year survival rate of over 50% can be achieved.

Authors with CRIS profile

Susanne Merkel Department of Surgery Robert Grützmann Lehrstuhl für Allgemein- und Viszeralchirurgie

How to cite

APA:

Handtrack, C., Weber, K., Merkel, S., Grützmann, R., & Denz, A. (2022). Treatment of locoregional recurrent colon cancer. Coloproctology. https://doi.org/10.1007/s00053-022-00608-x

MLA:

Handtrack, Claudia, et al. "Treatment of locoregional recurrent colon cancer." Coloproctology (2022).

BibTeX: Download